IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $668 | -77.7% | 37,500 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 37,500 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -62.5% | 37,500 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -97.8% | 37,500 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $365,000 | +1559.1% | 37,500 | 0.0% | 0.01% | +800.0% |
| Q3 2021 | $22,000 | -24.1% | 37,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $29,000 | – | 37,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |